InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Spiegel Robert J., Director. Insider active across 3 companies, notably Cyclacel Pharmaceuticals, Inc.. Cumulatively, 12 disclosures have been published. The latest transaction was filed on 30 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
04,637 shares0
Common Stock
SEC:0001062993-22-015792:0·
015,822 shares0
Common Stock
SEC:0001104659-22-071900:0·
€2,7613,989 shares@ €0.6921100.0% of flow
Common Stock
SEC:0001209191-22-024050:0·
05,284 shares0
Common Stock
SEC:0001062993-22-009237:0·
05,891 shares0
Common Stock
SEC:0001062993-22-000082·
05,891 shares0
Common Stock
SEC:0001062993-22-000082:0·
05,246 shares0
Common Stock
SEC:0001062993-21-009105·
05,246 shares0
Common Stock
SEC:0001062993-21-009105:0·
05,097 shares0
Common Stock
SEC:0000886744-21-000044·
05,097 shares0
Common Stock
SEC:0000886744-21-000044:0·
02,374 shares0
Common Stock
SEC:0001104659-21-082602·
02,374 shares0
Common Stock
SEC:0001104659-21-082602:0·
12 of 12 declarations
About Spiegel Robert J.
Robert J. Spiegel is a Board Member at Cyclacel Pharmaceuticals, Inc., Geron Corp, and Athenex, Inc. He brings expertise in biopharmaceuticals and product development to the board. His experience in the pharmaceutical sector contributes to guiding the strategic decisions of the companies.
